-+ 0.00%
-+ 0.00%
-+ 0.00%

Sangamo Therapeutics Announces Positive Phase 1/2 Data for Fabry Disease Gene Therapy Candidate

Reuters·02/03/2026 21:09:20

Please log in to view news